Early Study in Type 1 Diabetics of Ultra-rapid Insulin Formulation Shows Positive Topline Results
News
Adocia and Eli Lilly & Company recently published positive, topline results from a Phase 1b clinical trial evaluating BioChaperone Lispro — an ultra-rapid formulation of insulin lispro licensed to Lilly and using ... Read more